Canagliflozin editSet type / Edit
«Canagliflozin, sold under the brand name Invokana among others, is a medication used to treat type 2 diabetes. It is less preferred than metformin. It is used together with exercise and diet. It is not recommended in type 1 diabetes. It is taken by mouth.
Common side effects include vaginal yeast infections, nausea, constipation, and urinary tract infections. Serious side effects may include low blood sugar, Fournier's gangrene, leg amputation, kidney problems, high blood potassium, and low blood pressure.Diabetic ketoacidosis may occur despite nearly normal blood sugar levels. Use in pregnancy and breastfeeding is not recommended. Canagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It works by increasing the amount of glucose lost in the urine.
Canagliflozin was approved for medical use in the United States in 2013. A month's supply in the United Kingdom costs the NHS about £39.20 as of 2019. In the United States the wholesale cost of this amount is about US$475.20. In 2016 it was the 194th most prescribed medication in the United States with more than 3 million prescriptions.» (wikipedia)
Modified: 1 month ago on Jul 7, 2019
2 months ago on Jun 18, 2019.